[Research progress on the clinical features and mechanisms of COVID-19 combined with liver injury].
Zhonghua Gan Zang Bing Za Zhi
; 28(6): 523-527, 2020 Jun 20.
Article
in Chinese
| MEDLINE | ID: covidwho-654025
ABSTRACT
The highly contagious novel coronavirus pneumonia (COVID-19) that broke out in December 2019 has brought huge threats and losses to human society, so it has been the concern of every countries government. Presently, there are no specific drugs for COVID-19; however, a variety of potentially effective antiviral drugs, vaccines, cell therapies, traditional Chinese medicine and other methods are in clinical trials. Liver injury is a common complication of patients receiving COVID-19 treatment and its possible high incidence may affect the outcome of the disease. The pathogenesis of COVID-19 combined with liver injury in existing studies is still unclear, and relevant guidelines and expert consensuses are insufficient for clinical diagnosis and treatment. Therefore, the relevant progress and issues are now reviewed here.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Coronavirus Infections
/
Pandemics
/
Betacoronavirus
/
Liver Diseases
Type of study:
Observational study
/
Prognostic study
Topics:
Long Covid
/
Traditional medicine
/
Vaccines
Limits:
Humans
Language:
Chinese
Journal:
Zhonghua Gan Zang Bing Za Zhi
Journal subject:
Gastroenterology
Year:
2020
Document Type:
Article
Affiliation country:
Cma.j.cn501113-20200416-00190
Similar
MEDLINE
...
LILACS
LIS